Vemurafenib oral bioavailability: an insoluble problem.
Russell Z
RZ
Szmulewitz
Mark J
MJ
Ratain
D000970:Antineoplastic Agents / Q000493:pharmacokinetics*; D004041:Dietary Fats / Q000493:pharmacokinetics*; D005260:Female; D018565:Food-Drug Interactions; D006801:Humans; D007211:Indoles / Q000493:pharmacokinetics*; D008297:Male; D008545:Melanoma / Q000378:metabolism*; D047428:Protein Kinase Inhibitors / Q000493:pharmacokinetics*; D013449:Sulfonamides / Q000493:pharmacokinetics*; D000077484:Vemurafenib
D000970:Antineoplastic Agents; D004041:Dietary Fats; D007211:Indoles; D047428:Protein Kinase Inhibitors; D013449:Sulfonamides; D000077484:Vemurafenib